Biology Reference
In-Depth Information
Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E
activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851-854
Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ (1995) Novel INK4 proteins, p19 and p18,
are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol
15:2672-2681
Hose D, Reme T, Meissner T, Moreaux J, Seckinger A, Lewis J, Benes V, Benner A, Hundemer
M, Hielscher T, Shaughnessy JD Jr, Barlogie B, Neben K, Kramer A, Hillengass J, Bertsch U,
Jauch A, De Vos J, Rossi JF, Mohler T, Blake J, Zimmermann J, Klein B, Goldschmidt H
(2009) Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.
Blood 113:4331-4340
Hsu LC, White RL (1998) BRCA1 is associated with the centrosome during mitosis. Proc Natl
Acad Sci U S A 95:12983-12988
Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM,
Staudt LM (2004) Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that
promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 5:191-199
Iovino F, Lentini L, Amato A, Di Leonardo A (2006) RB acute loss induces centrosome
amplification and aneuploidy in murine primary fibroblasts. Mol Cancer 5:38
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics 2010. CA Cancer J Clin 60:277-300
Juge-Morineau N, Harousseau JL, Amiot M, Bataille R (1997) The retinoblastoma susceptibility
gene RB-1 in multiple myeloma. Leuk Lymphoma 24:229-237
Kramer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann
R (2002) Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Leukemia 16:1844-1851
Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR,
Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA (2008) Improved survival in
multiple myeloma and the impact of novel therapies. Blood 111:2516-2520
Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, Pellman D (2008)
Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes
Dev 22:2189-2203
Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860-1873
Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
N Engl J Med 346:564-569
Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome
duplication. Proc Natl Acad Sci U S A 96:2817-2822
Lee MH, Yang HY (2003) Regulators of G1 cyclin-dependent kinases and cancers. Cancer
Metastasis Rev 22:435-449
Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R (2002) p21-
activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO
Rep 3:767-773
Liu Q, Aurora.A Ruderman JV (2006) Mitotic entry, and spindle bipolarity. Proc Natl Acad Sci U
S A 103:5811-5816
Manthey C, Mern DS, Gutmann A, Zielinski AJ, Herz C, Lassmann S, Hasskarl J (2010) Elevated
endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates
with significant centrosome abnormalities in human tumor cells. BMC Cell Biol 11:2
Mateos MV, Garcia-Sanz R, Lopez-Perez R, Moro MJ, Ocio E, Hernandez J, Megido M, Caballero MD,
Fernandez-Calvo J, Barez A, Almeida J, Orfao A, Gonzalez M (2002) San Miguel JF. Methylation is
an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell
proliferation and short survival. Br J Haematol 118:1034-1040
Maxwell CA, Pilarski LM (2005) A potential role for centrosomal deregulation within IgH
translocation-positive myeloma. Med Hypotheses 65:915-921
Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM
(2003) RHAMM is a centrosomal protein that interacts with dynein and maintains spindle
pole stability. Mol Biol Cell 14:2262-2276
